Ilias Nikas

ilias_nikas.png

 

HISTOLOGY

LABORATORY

 

" Advancing Laboratory Medicine with AI"

Ilias Nikas is an Assistant Professor of Histology at the Medical School, University of Cyprus. He studied Medicine at the University of Thessaloniki, Greece, and performed his doctoral research at the Institute of Pathology, Technical University Munich, Germany. He completed the fellowship program for foreign physicians in the field of Molecular Pathology at the Department of Pathology, Seoul National University, Korea. He also received training in the field of Digital Pathology and Image Analysis at the National Center of Pathology, Vilnius University, Lithuania. Ilias Nikas is a Cytopathologist and a Member of the International Academy of Cytopathology. His research interests focus on the fields of Molecular Pathology and Immunology of Solid Tumors, Molecular Cytopathology, Digital Pathology, and Medical Education related to Histology and Pathology. He also performs systematic reviews and meta-analyses of diagnostic test accuracy studies.

 

Assistant Professor Ilias Nikas

Medical School, University of Cyprus      

This email address is being protected from spambots. You need JavaScript enabled to view it.; (+357) 22 895281

 


Screenshot_2025-11-02_at_8.32.54 PM.png

 

Screenshot_2025-11-02_at_8.33.33 PM.png

 

Screenshot_2025-11-02_at_8.34.45 PM.png

 

Cancer Biomarkers

The aim is to evaluate potential diagnostic, prognostic, and therapeutic biomarkers in various solid malignancies, including the breast, lung, pancreas, urinary bladder, and ovaries. Testing is performed on tissue biopsies or cytologic material (e.g., serous effusions), while each biomarker expression is correlated with various clinicopathological parameters (e.g., tumor grading, staging, response to therapy) and survival in well-characterized patient cohorts. Emerging biomarkers related to the immune microenvironment and response to immunotherapy are also assessed.

Screenshot_2025-11-02_at_8.35.50 PM.png

Screenshot_2025-11-02_at_8.36.16 PM.png

Digital Pathology and AI in

Laboratory Medicine and Medical Education

The aim is to advance laboratory medicine, facilitate workflow and enhance precision. Projects include evaluating various diagnostic, prognostic, and predictive cancer biomarkers with the aid of virtual microscopy and AI, testing algorithms that detect neoplasia in clinical samples and using AI as a screening tool in cytologic samples. In medical education, the goal is to integrate AI with histology teaching and assess its effect in student learning outcomes. Applications include the evaluation of histologic slides with AI as a guide, also the creation of active learning tools that help students enhance their microscopy skills and integrate their findings with relevant clinicopathological parameters and radiologic findings.

Screenshot_2025-11-02_at_8.37.13 PM.png

image2_nikas.png

 

Screenshot_2025-11-02_at_8.38.22 PM.png

 

Screenshot_2025-11-02_at_8.38.52 PM.png 

Systematic Reviews and Meta-analyses of

Diagnostic Test Accuracy Studies

The aim is to provide high-quality evidence and improve patient care in the field of laboratory medicine. Projects include evaluating the diagnostic performance of potential or well-established diagnostic biomarkers in tissue or cytology samples and the diagnostic accuracy of various reporting systems.

Screenshot_2025-11-02_at_8.40.10 PM.png

Screenshot_2025-11-02_at_8.40.40 PM.png

 

 

 

SELECTED GRANTS
  1. COST Action CA21116 (2022-2026): Identification of biological markers for prevention and translational medicine in pancreatic cancer
SELECTED PUBLICATIONS
  1. Kleinaki M, Vey JA, Awounvo S, Ishak A, Arnaouti M, et al. The Diagnostic Accuracy of Claudin-4 Immunochemistry in Differentiating Metastatic Carcinomas From Mesothelial Processes in Serous Effusion Cytology: A Systematic Review and Meta-analysis. Arch Pathol Lab Med. 2024 Jun 14. doi: 10.5858/arpa.2023-0560-RA. Epub ahead of print. PMID: 38871358.
  2. Ntostoglou K, Theodorou SDP, Proctor T, Nikas IP, Awounvo S, et al. Distinct profiles of proliferating CD8+/TCF1+ T cells and CD163+/PD-L1+ macrophages predict risk of relapse differently among treatment-naïve breast cancer subtypes. Cancer Immunol Immunother. 2024 Feb 13;73(3):46. doi: 10.1007/s00262-024-03630-8. PMID: 38349444; PMCID: PMC10864422.
  3. Nikas IP, Lim S, Im SA, Lee KH, Lee DW, et al. Discrepancies in Hormone Receptor and HER2 Expression between Malignant Serous Effusions and Paired Tissues from Primary or Recurrent Breast Cancers. Pathobiology. 2024;91(3):169-179. doi: 10.1159/000533912. Epub 2023 Oct 10. PMID: 37816333
  4. Jung M, … Nikas IP, et al. Artificial intelligence system shows performance at the level of uropathologists for the detection and grading of prostate cancer in core needle biopsy: an independent external validation study. Mod Pathol. 2022 Oct;35(10):1449-1457. doi: 10.1038/s41379-022-01077-9. Epub 2022 Apr 29. PMID: 35487950.
  5. Nikas IP, et al. Shift to emergency remote preclinical medical education amidst the Covid-19 pandemic: A single-institution study. Anat Sci Educ. 2022 Jan;15(1):27-41. doi: 10.1002/ase.2159. PMID: 34854255; PMCID: PMC9011537.